US-FDA Audit of Arevipharma

We are pleased to inform you that our German Production Partner Arevipharma was successfully inspected by the US Food and Drug Administration (US-FDA) from 25. – 29. April 2016.

The audit has covered all quality systems, equipment and facilities, materials, production, packaging, labeling and laboratory controls.

Of course we are very proud to announce, that the US-FDA inspection was successfully concluded and finalized without any objections.

This is another demonstration of the commitment of Arevipharma and AXXO’s, which is to work with excellent quality standards and in full compliance with the different international guidelines of the good manufacturing practice (GMP). We guarantee to work under excellent quality standards and that our product portfolio meets highest standards in all international markets.